You are here » Home » Companies » Company Overview » Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd.

BSE: 532989 Sector: Health care
NSE: BAFNAPHARM ISIN Code: INE878I01014
BSE LIVE 15:40 | 09 Dec 30.55 0.05
(0.16%)
OPEN

30.90

HIGH

31.00

LOW

30.15

NSE LIVE 15:31 | 09 Dec 30.50 0.15
(0.49%)
OPEN

30.20

HIGH

31.20

LOW

30.10

OPEN 30.90
PREVIOUS CLOSE 30.50
VOLUME 4692
52-Week high 52.40
52-Week low 25.50
P/E
Mkt Cap.(Rs cr) 57.01
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 30.90
CLOSE 30.50
VOLUME 4692
52-Week high 52.40
52-Week low 25.50
P/E
Mkt Cap.(Rs cr) 57.01
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Ltd

Bafna was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products. The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p....> More

Bafna Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   57
EPS - TTM () [*S] -
P/E Ratio (X) [*S] -
Face Value ()   10
Latest Dividend (%)   6.00
Latest Dividend Date 19 Sep 2013
Dividend Yield (%) 0.00
Book Value / Share () [*S] 28.29
P/B Ratio () [*S] 1.08
[*C] Consolidated     [*S] Standalone

Bafna Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 16.49 15.99 3.13
Other Income 0.17 0.73 -76.71
Total Income 16.65 16.72 -0.42
Total Expenses 16.29 14.59 11.65
Operating Profit 0.36 2.13 -83.1
Net Profit -3.75 -2.41 -55.6
Equity Capital 18.66 18.66 -
> More on Bafna Pharmaceuticals Ltd Financials Results

Bafna Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Vikram Thermo 113.30 2.07 63.22
Ambalal Sarabhai 8.11 -0.25 62.15
Mercury Labs 507.00 -2.65 60.84
Bafna Pharma. 30.55 0.16 57.01
Natural Capsules 88.85 -2.36 55.35
Panch.Organics 106.55 -4.01 53.49
Parabolic Drugs 8.06 -1.23 49.88
> More on Bafna Pharmaceuticals Ltd Peer Group

Bafna Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 33.42
Banks/FIs 0.08
FIIs 0.00
Insurance 0.00
Mutual Funds 0.00
Indian Public 57.63
Custodians 0.00
Other 8.87
> More on Bafna Pharmaceuticals Ltd Share Holding Pattern

Bafna Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -0.49% -0.97% 1.97% 2.16%
1 Month -2.08% -1.13% -1.85% -2.02%
3 Month 7.95% 6.83% -7.12% -6.82%
6 Month 4.98% 5.72% -0.06% 0.71%
1 Year -21.36% -21.29% 6.83% 8.53%
3 Year 15.07% 14.88% 25.42% 29.82%

Bafna Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 30.15
31.00
Week Low/High 30.00
31.00
Month Low/High 26.25
34.00
YEAR Low/High 25.50
52.00
All TIME Low/High 8.85
60.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard